Related references
Note: Only part of the references are listed.The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas
Brian D. Adams et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3
Zhize Chen et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors
Muhammad Shaalan Beg et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer
Xin Dai et al.
MOLECULAR PHARMACEUTICS (2016)
Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells
Chun-Yu Cho et al.
RNA (2016)
MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN
Ping Ren et al.
TUMOR BIOLOGY (2016)
MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2
Jing Xie et al.
TUMOR BIOLOGY (2016)
miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9
Lin Wu et al.
ONCOLOGY LETTERS (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery
Yao Sun et al.
ACS NANO (2016)
MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1
Gang Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD
Yi Zhang et al.
BMC CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
Weili Li et al.
CANCER CELL INTERNATIONAL (2016)
Low-molecular-mass secretome profiling identifies prognostic biomarkers for oral cavity squamous cell carcinomas
Kai-Ping Chang et al.
CANCER RESEARCH (2016)
miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers
Stephanie Langsch et al.
CANCER RESEARCH (2016)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine
Nicholas C. K. Valerie et al.
CANCER RESEARCH (2016)
被撤回的出版物: Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration via TGF beta RII Inhibition (Retracted article. See vol. 39, pg. 1964, 2016)
Jianying Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
MicroRNA-21 Regulates Non-Small Cell Lung Cancer Cell Invasion and Chemo-Sensitivity through SMAD7
Lei Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Sequential Serum Let-7 Is a Novel Biomarker to Predict Accelerated Reproliferation During Fractional Radiotherapy in Lung Cancer
Peng Xie et al.
CLINICAL LUNG CANCER (2016)
Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
Jiali Yang et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Wnt signaling as potential therapeutic target in lung cancer
Jiali Yang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Role of microRNAs in the metastasis of non-small cell lung cancer
XinWei Han
Frontiers in Bioscience-Landmark (2016)
Over expression of miR-200c suppresses invasion and restores methotrexate sensitivity in lung cancer A549 cells
Wulin Shan et al.
GENE (2016)
Upregulation of microRNA-450 inhibits the progression of lung cancer in vitro and in vivo by targeting interferon regulatory factor 2
Fabing Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
Maryna Perepelyuk et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
Jing Han et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
Nobuhiko Nishijima et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014
Benjamin J. Solomon et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
Merve Mutlu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer
Jenny T. Mao et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
被撤回的出版物: MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator (Retracted article. See vol. 24, pg. 573, 2021)
Aihong Jiao et al.
MOLECULAR MEDICINE REPORTS (2016)
FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1
Joohee Sul et al.
ONCOLOGIST (2016)
NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
Ching-Feng Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
MicroRNA 25, microRNA 145, and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations
Sheng-Bin Shi et al.
TRANSLATIONAL RESEARCH (2016)
miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2
Shuo Zhang et al.
TUMOR BIOLOGY (2016)
miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis
Chiranjib Chakraborty et al.
TUMOR BIOLOGY (2016)
Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
Zhiqiang Ye et al.
ONCOTARGET (2016)
Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
Yang Shao et al.
ONCOTARGET (2016)
miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13
Shudi Xu et al.
ONCOTARGET (2016)
MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma
Ling Chen et al.
ONCOTARGET (2016)
Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer
Cheng-Cao Sun et al.
ONCOTARGET (2016)
Is there a progression-free survival benefit of first-line crizotinib versus standard chemotherapy and second-line crizotinib in ALK-positive advanced lung adenocarcinoma? A retrospective study of Chinese patients
Shaohua Cui et al.
CANCER MEDICINE (2016)
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
Margherita Iaboni et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Associations of mRNA:microRNA for the Shared Downstream Molecules of EGFR and Alternative Tyrosine Kinase Receptors in Non-small Cell Lung Cancer
Fengfeng Wang et al.
FRONTIERS IN GENETICS (2016)
Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
Thomas K. Sin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Assunta Sgambato et al.
CURRENT DRUG SAFETY (2016)
被撤回的出版物: Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN (Retracted article. See vol. 53, pg. 1743, 2021)
Naixin Liang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
Small molecule compounds targeting miRNAs for cancer therapy
Paloma del C. Monroig et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
Huiyuan Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3
Bin Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells
Hongyang Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Achieving successful delivery of oligonucleotides - From physico-chemical characterization to in vivo evaluation
Anna Scomparin et al.
BIOTECHNOLOGY ADVANCES (2015)
miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells
Z. Zhao et al.
CANCER GENE THERAPY (2015)
Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
Carlos Stahlhut et al.
CELL CYCLE (2015)
miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer
Fang Liu et al.
CELL PROLIFERATION (2015)
MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2
An Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
miR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis
Abhisek Chatterjee et al.
CELLULAR SIGNALLING (2015)
MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer
Qiang Zhen et al.
CYTOGENETIC AND GENOME RESEARCH (2015)
MicroRNAs in cancer therapeutics: from the bench to the bedside
Paloma del C. Monroig-Bosque et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
The emerging rile of miRNAs in combined cancer therapy
Hong W. Yu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1
Huanxin Liu et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2015)
MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation
Xuguang Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Molecularly Targeted Therapies in Non-Small-Cell Lung Cancer Annual Update 2014
Daniel Morgensztern et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
An interactive web application for the dissemination of human systems immunology data
Cate Speake et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
MicroRNA as tools and therapeutics in lung cancer
Jennifer F. Barger et al.
RESPIRATORY MEDICINE (2015)
Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer
Fei Han et al.
BIOMED RESEARCH INTERNATIONAL (2015)
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Christopher J. Cheng et al.
NATURE (2015)
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
A. L. Kasinski et al.
ONCOGENE (2015)
miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer
S. Fernandez et al.
ONCOGENE (2015)
Upregulation of the miR-212/132 cluster suppresses proliferation of human lung cancer cells
Xin Jiang et al.
ONCOLOGY REPORTS (2015)
Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells
Hongmei Wang et al.
PLOS ONE (2015)
Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42
Tian Yang et al.
TUMOR BIOLOGY (2015)
Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A
Banzhou Pan et al.
ONCOTARGET (2015)
Assessment of the protection of dopaminergic neurons by an alpha 7 nicotinic receptor agonist, PHA 543613 using [F-18]LBT-999 in a Parkinson's disease rat model
Sophie Serriere et al.
FRONTIERS IN MEDICINE (2015)
A novel miRNA-mediated STOP sign in lung cancer: miR-340 inhibits the proliferation of lung cancer cells through p27KIP1
Serena Fernandez et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
H. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3
Bingtian Zhao et al.
CANCER LETTERS (2014)
miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14
Ning Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Decreased Expression of miR216a Contributes to Non-Small-Cell Lung Cancer Progression
Ren-Tao Wang et al.
CLINICAL CANCER RESEARCH (2014)
Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
Rick F. J. Kwekkeboom et al.
CLINICAL SCIENCE (2014)
MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
Fang-ling Ning et al.
DIAGNOSTIC PATHOLOGY (2014)
Development of microRNA therapeutics is coming of age
Eva van Rooij et al.
EMBO MOLECULAR MEDICINE (2014)
MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc
Dongqin Chen et al.
EUROPEAN JOURNAL OF CANCER (2014)
miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
Jipeng Li et al.
MOLECULAR CANCER (2014)
MiR-134/487b/655 Cluster Regulates TGF-β-Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
Kazuhiro Kitamura et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Maria Angelica Cortez et al.
MOLECULAR THERAPY (2014)
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
Bing Li et al.
LUNG CANCER (2014)
In-Depth Analysis Shows Synergy between Erlotinib and miR-34a
Jane Zhao et al.
PLOS ONE (2014)
The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells
Yang Shi et al.
PLOS ONE (2014)
Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
Hua Shen et al.
PLOS ONE (2014)
The potential clinical applications and prospects of microRNAs in lung cancer
Ying Gao et al.
ONCOTARGETS AND THERAPY (2014)
Cavity-free plasmonic nanolasing enabled by dispersionless stopped light
Tim Pickering et al.
NATURE COMMUNICATIONS (2014)
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
G. Reid et al.
ANNALS OF ONCOLOGY (2013)
microRNAs as Mediators of Drug Toxicity
Tsuyoshi Yokoi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model
Q. L. Hu et al.
BIOMATERIALS (2013)
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Federico Mingozzi et al.
BLOOD (2013)
MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer
Huijun Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer
Lu Lu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Progress in microRNA delivery
Yu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Liposome Delivery of MicroRNA-145 to Mesenchymal Stem Cells Leads to Immunological Off-target Effects Mediated by RIG-I
Tommy A. Karlsen et al.
MOLECULAR THERAPY (2013)
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Yun Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines
Yong-Sheng Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma
Andrea L. Kasinski et al.
CANCER RESEARCH (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma
Guang-Yuh Chiou et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Double-stranded Let-7 mimics, potential candidates for cancer gene therapy
Qi-zhao Wang et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2012)
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
V. J. Craig et al.
LEUKEMIA (2012)
Long-term, efficient inhibition of microRNRNA function in mice using rAAV vectors
Jun Xie et al.
NATURE METHODS (2012)
Regression of A549 lung cancer tumors by anti-miR-150 vector
You-Jie Li et al.
ONCOLOGY REPORTS (2012)
RNAimmuno: A database of the nonspecific immunological effects of RNA interference and microRNA reagents
Marta Olejniczak et al.
RNA (2012)
Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7
Zhiwei Zhong et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ahmed Fawzy Ibrahim et al.
CANCER RESEARCH (2011)
Developing therapeutic microRNAs for cancer
A. G. Bader et al.
GENE THERAPY (2011)
Cytoplasmic DNA innate immune pathways
Glen N. Barber
IMMUNOLOGICAL REVIEWS (2011)
The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?
Benjamin Purow
JOURNAL OF NEURO-ONCOLOGY (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA
Saurabh Singh et al.
PHARMACEUTICAL RESEARCH (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
Markus Wallwiener et al.
BMC CANCER (2010)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
Emerging Roles for Natural MicroRNA Sponges
Margaret S. Ebert et al.
CURRENT BIOLOGY (2010)
MicroRNAs as therapeutic targets for lung cancer
William C. S. Cho
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Small Molecule Modifiers of MicroRNA miR-122 Function for the Treatment of Hepatitis C Virus Infection and Hepatocellular Carcinoma
Douglas D. Young et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes
Fumitaka Takeshita et al.
MOLECULAR THERAPY (2010)
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Yunching Chen et al.
MOLECULAR THERAPY (2010)
Regression of murine lung tumors by the let-7 microRNA
P. Trang et al.
ONCOGENE (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Role of miRNAs in lung cancer
William C. S. Cho
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4
Derek S. Wheeler et al.
RESPIRATORY RESEARCH (2009)
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
Aurora Esquela-Kerscher et al.
CELL CYCLE (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Margaret S. Ebert et al.
NATURE METHODS (2007)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
Identification of novel genes coding for small expressed RNAs
M Lagos-Quintana et al.
SCIENCE (2001)
Share Paper
